transgene-biotek-ltd
Home
Transgene Biotek Ltd
null Share Price
BSE:
NSE:
null Share Price
BSE:
NSE:
Healthcare
Small Cap
₹-
0 (0%)
Market Cap
₹57.59 Cr
Transgene Biotek Ltd Performance
▲
▲
▲
▲
Transgene Biotek Ltd Fundamentals
Transgene Biotek Ltd Delivery and Volume
About Transgene Biotek Ltd
Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India. Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology ,
| Name | Designation |
|---|---|
| Sujana Kadiam | Independent Director |
| Ankita Jain | Company Sec. & Compli. Officer |
| Santosh Kumar | Independent Director |
| K Koteswara Rao | Chairman & Managing Director |
| Marri Swetha | Independent Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Transgene Biotek Ltd FAQs
How do I Buy Transgene Biotek Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Transgene Biotek Ltd shares in BlinkX.
What is the Share Price of Transgene Biotek Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Transgene Biotek Ltd's share price is ₹7.6 as of 2024-12-13.
What is the PE ratio of Transgene Biotek Ltd?
Transgene Biotek Ltd's P/E ratio is - times as of 2024-12-13.
What is the PB ratio of Transgene Biotek Ltd?
Transgene Biotek Ltd's most recent financial reports indicate a price-to-book ratio of 5.32, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Transgene Biotek Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Transgene Biotek Ltd's market capitalization is ₹57.59 Cr as on 2024-12-13.
What is the ROE of Transgene Biotek Ltd?
The current financial records of Transgene Biotek Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Transgene Biotek Ltd?
According to Transgene Biotek Ltd's most recent financial filings, the company has a total asset value of ₹1.1, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Transgene Biotek Ltd?
The 52-week high/low price of a Transgene Biotek Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Transgene Biotek Ltd's 52-week high and low as of 2024-12-13 are ₹7.8 and ₹7.14, respectively.
